Introduction
The Toll family of receptors, the founding family of pathogen sensors in the innate immune system, senses a variety of microbial products. Cell surface Toll-like receptors (TLRs) including TLR4/MD-2, TLR1/TLR2 and TLR6/TLR2 recognize microbial membrane lipids, whereas TLR3, TLR7, TLR8 and TLR9 reside in intracellular organelles and recognize microbial nucleic acids (1-3). TLRs activate innate immune responses and prime adaptive immune responses by inducing nuclear factor κB (NF-κB)-dependent proinflammatory cytokines, interferon regulatory factor (IRF)-dependent type I interferons and costimulatory molecules.
TLR5 reacts with a protein ligand called flagellin, the major structural protein of bacterial flagella (4) . The role for TLR5 in host responses against pathogenic and commensal bacteria is complicated. During urinary-tract infection by Escherichia coli, defects in TLR5 result in decreased inflammation and increases bacterial burden (5) . On the other hand, in Legionella pneumophila infection in the lungs, TLR5 facilitates early neutrophil recruitment, but negatively regulates subsequent development of pneumonia (6) . Further, TLR5 −/− mice are reported to show enhanced resistance against oral Salmonella infection (7). Although TLR5 −/− mice are reported to develop colitis and metabolic defects due to dysregulated host response to intestinal flora (8, 9) , another study fails to see these phenotypes in other colonies of TLR5 −/− mice (10) . The discrepancy among previous reports extends to TLR5 expression. Flagellin is reported to activate murine bone marrow-derived dendritic cells (BM-DCs), and to be a promising adjuvant that effectively activates the acquired immune system (11, 12) . Interestingly, splenic DCs show 10-fold higher expression of TLR5 mRNA than BM-DCs (12) . On the contrary, in another report, TLR5 mRNA is highly expressed in murine intestinal lamina propria dendritic cells (DCs), but not in BM-DCs or BM-macrophages (7) . TLR5 expression in intestinal epithelial cells is also controversial, being positive in some reports while negative in other reports (7, 13) .
Furthermore, although TLR5 is considered one of the cell surface TLRs, cell surface expression of endogenous TLR5 has never been verified. Intestinal epithelia overexpressing TLR5 were initially believed to express TLR5 on the basolateral surface and recognize invading pathogens (13) , but cell surface localization of endogenous TLR5 remains unclear. Recent studies demonstrated endogenous TLR5 on the surface of equine and human neutrophils (14, 15) , but further results on other immune cells have not been reported.
TLR5 is distinct from other cell surface TLRs, such as TLR2 and TLR4, in that TLR5 do not require adaptor protein TIRAP (Toll-interleukin-1 receptor domain-containing adaptor protein) to induce myeloid differentiation factor 88 (MyD88) signaling from cell surface (16) . TIRAP is required for MyD88 recruitment to the plasma membrane, raising a question whether TLR5 signals from the cell surface (17) . Two molecules are reported to be required for cell surface expression of TLRs; PRAT4A (protein associated with TLR4 A) and a general chaperone gp96 are both required for cell surface expression of TLR4/MD-2 (18) (19) (20) . PRAT4A is associated with gp96 and work as a TLR-specific cochaperone for gp96 (21) . These chaperones are also required for trafficking of intracellular TLRs including TLR9. Although gp96 has been shown to be required for macrophage response to flagellin (20) , this result does not necessarily demonstrate cell surface expression of TLR5.
In this study we established an anti-TLR5 monoclonal antibody and examined cell surface expression of TLR5 on a variety of immune cells. We also showed requirement for PRAT4A in cell surface expression and responses of TLR5.
Methods

Mice
BALB/c background mice were used for all experiments, except for those presented in Figures 4 and 8A , for which wild-type C57BL/6 mice were used. Wild-type BALB/c and C57BL/6 mice were purchased from Japan slc, Inc. (Shizuoka, Japan).
BALB/c PRAT4A −/− mice, backcrossed with the BALB/c strain for 10 generations, were previously reported (22) . TLR5 −/− mice on the C57BL/6 background were introgressively backcrossed to the BALB/c strain for seven generations, and used as BALB/c TLR5 −/− mice. All animal experiments were conducted with the approval of the Animal Research Committee of the Institute of Medical Science, The University of Tokyo.
Generation of anti-mouse TLR5 monoclonal antibodies
To establish an anti-mouse TLR5 monoclonal antibody (mAb), BALB/c TLR5 −/− mice were immunized several times with Ba/ F3 cells expressing green fluorescent protein conjugated mouse TLR5 (Ba/F3_mTLR5GFP). Four days after the final immunization, splenic cells were fused with SP2/O myeloma cells using GenomONE-CF (Ishihara Sangyo Kaisha, Ltd, Osaka, Japan). After hypoxanthine-aminopterinthymidine (HAT) selection, a hybridoma-producing anti-mouse TLR5 mAb was selected due to its strong reactivity to immunized Ba/F3 cells expressing mTLR5GFP, but not to parental Ba/ F3 cells in flow cytometry. This mAb, named ACT5 (mouse IgG1/κ), also stained Ba/F3 cells expressing untagged mouse TLR5 (Fig. 1B) . Anti-mouse PRAT4A mAb (4A10) and anti-mouse TLR2 mAb (CB225) were also established in our laboratory and will be described elsewhere. Purity of ACT5 was verified by SDS-PAGE and coomassie brilliant blue staining and used for subsequent analyses after biotinylation.
Reagents and cells
Rabbit anti-GFP polyclonal antibody (pAb) for western blotting was purchased from Invitrogen and anti-GFP (FM264) mAb for immunoprecipitation was previously established in our laboratory (19) . Rabbit anti-PRAT4A antisera for western blotting was also established in our laboratory (18) .
Ultrapure flagellin purified from S. typhimurium and lipid A purified from S. minnesota (Re-595) were purchased from InvivoGen and Sigma-Aldrich, respectively. Pam 3 CSK 4 was purchased from EMC Microcollections. RAW264.7, P388D1 and J774 cells were cultured in Dulbecco's Modified Eagle Medium (DMEM) supplemented with 10% FBS, penicillin-streptomycinglutamine (GIBCO) and 50 μM 2-ME. Ba/F3, M1 and 32D cells were cultured in Roswell Park Memorial Institute (RPMI) 1640 medium supplemented with 10% FBS, penicillin-streptomycinglutamine and 50 μM 2-ME. IL-3 was added into culture medium for Ba/F3 and 32D cells. Construction of Ba/F3 with NF-κB-GFP (BaκB) was previously described (23) . Mouse TLR5, mouse TLR5-GFP and human TLR5 were cloned into retroviral vector pMX-puro and transduced with retrovirus made from Plat-E packaging cells into Ba/F3, BaκB or J774 cells. Transduced cells were selected by puromycin treatment. To suppress mouse PRAT4A expression in Ba/F3 and J774 cells, we also constructed retroviral vector pSSCH expressing shRNA whose targeting sequence was 5ʹ-gagtttgaagaggtgattgag-3ʹ (24) , and transduced into cells using same strategy in pMX-puro. As a control, we used cells expressing an empty vector.
Bone marrow (BM)-derived dendritic cells and macrophages were prepared as described previously (19) . For preparation of BM-DCs, BM cells recovered from tibiae and femora were plated at 10 6 cells per milliliter in 24-well plates with RPMI 1640 medium supplemented with 10% FBS, penicillin-streptomycin-glutamine, 50 μM 2-ME and 10 ng ml -1 of recombinant murine GM-CSF (PeproTech, Rocky Hill, NJ). Half volume of medium was changed every other day. For BM-macrophages, BM cells were plated at 7 × 10 6 cells 10 ml −1 in nontissue culture treated 10 cm dishes with DMEM supplemented with 10% FBS, penicillin-streptomycinglutamine, 50 μM 2-ME and 100 ng ml -1 recombinant murine M-CSF (PeproTech, Rocky Hill, NJ). At day 6, both cells were harvested and used for flow cytometry analysis. Peritoneal exudate cells (PECs) were collected by lavage with 10 ml of HBSS from mice that had been intraperitoneally injected 2.5 ml of thioglycollate 12 or 72 h before collecting PECs, and cultured with DMEM supplemented with 10% FBS, penicillinstreptomycin-glutamine and 50 μM 2-ME.
Cell staining and sorting
BM cells and splenocytes were stained with fluorescein-conjugated antibodies specific for the following markers in flow cytometry analysis: CD4 (GK1.5), CD8α (53-6.7), CD11b (M1/70), CD11c (HL3), B220 (RA3-6B2), Ter119/Erythroid Cells (Ter119), CD43 (S7), Ly6C (HK1.4), Ly6G (1A8) and Gr-1 (RB6-8C5). Biotinylated anti-TLR4/MD-2 (MTS510), anti-TLR2 (CB225) and anti-CD14 (Sa2-8) mAbs were previously established in our laboratory (25, 26) .
For preparation of single cell splenocyte suspensions, spleens were minced by scissors and incubated for 30 min at 37°C in RPMI with 0.09 U ml -1 Liberase TL (Roche) and 0.1 mg ml -1 DNase I (Roche). Finally, suspended splenocytes were teased through nylon mesh after pipetting several times, and subjected to cell staining.
The cell staining procedure for flow cytometry analysis was performed in staining buffer (1 × PBS with 2.5% FBS and 0.1% NaN 3 ). Single cell suspensions were incubated on ice for 20 min with biotinylated mAbs diluted in staining buffer. Then cells were washed and incubated with PE-streptavidin (Biolegend) and fluorescein-conjugated mAbs for 15 min. Stained cells were analyzed by the FACSCallibur or FACSAria flow cytometers (BD Biosciences).
The cell staining procedure for sorting was performed in staining buffer (1 × PBS with 10% FBS, 10 mM HEPES and 1 mM sodium pyruvate). Sorting methods for BM-derived neutrophils and classical monocytes are described in Fig. 7A . All cell populations were sorted by FACSAria.
May-Grünwald-Giemsa staining
Sorted cells were attached to slides by cytospin preparation and subjected to staining by May-Grünwald stain (Wako, Japan) and Giemsa solution (Wako, Japan) according to manufacturer's instructions.
Immunoprecipitation and immunoprobing
All cells were washed and lysed in lysis buffer consisting 1% Triton X-100, 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 5 mM EDTA, 1 mM PMSF, 10 μg ml -1 aprotinin and 10 μg ml -1 leupeptin. After incubation for 30 min on ice, lysates were centrifuged and debris was removed. The N-hydroxysuccinimide-activated Sepharose 4FF beads coupled with ACT5, FM264 or 4A10 
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were added to cell lysates and rotated for 2 h at 4°C. The beads were then washed in lysis buffer three times and bound proteins were subjected to SDS-PAGE and western blotting. Using 4A10 beads, cells were treated with 1 mM dithiobis (succinimidylpropionate), a cross-linking reagent, for 30 min at room temperature before cell lysis.
Cytokine measurement
J774 cells, BM-DCs, BM-macrophages, sorted BM-derived neutrophils and classical monocytes, plated at 1 × 10 5 per well on 96-well plates, were stimulated with indicated TLR ligands for 24 h. The supernatant of cell culture was collected and IL-6 and MCP-1 production was measured by ELISA kits (R&D systems). The concentration of G-CSF and other cytokines (TNF-α, IL-6, IL-10, IL-12p40, G-CSF, GM-CSF, RANTES, MIP-1α, IP-10 and KC) were comprehensively measured by a MILLIPLEX Map Mouse Cytokine/ Chemokine 22-plex (Millipore), following to the manufacturer's instructions.
Quantitative real-time PCR
Quantitative PCR was conducted as described previously (22) . Briefly, total RNA (1 μg) was reverse transcribed into cDNA using ReverTra Ace qPCR RT Kit (TOYOBO). Quantitative PCR assays were analyzed by a 7300 Fast Real Time PCR System (Applied Biosystems) with TaqMan Gene Expression Assays for mouse PRAT4A (Mm00511161). Each sample was normalized with TaqMan Gene Expression Assays for mouse β-actin (Mm00607939).
Statistical analysis
Data from triplicate samples were used for statistical analysis. Statistical significance was calculated by the Student's t-test. A P value of <0.01 was considered to be significant.
Results
Establishment of monoclonal anti-TLR5
To establish an anti-TLR5 monoclonal antibody, we established TLR5-expressing Ba/F3 cells for immunization. To make sure that ectopically expressed TLR5 is functional in Ba/F3 cells, mouse TLR5 was also expressed in Ba/F3 cells with a reporter construct NF-κB-GFP (BaκB), which enabled NF-κB-dependent GFP induction. GFP induction in TLR5-expressing BaκB cells was seen when stimulated with flagellin, demonstrating that TLR5 is functional in Ba/F3 cells (Fig. 1A) . BaκB cells expressing human TLR5 also showed flagellin-dependent GFP induction. TLR5 −/− mice on the BALB/c background were immunized with Ba/F3 cells expressing mouse TLR5-GFP, and their splenocytes were used for hybridoma establishment. The first screening used staining of immunized TLR5-GFP expressing Ba/F3 cells, on which cell surface expression of TLR5-GFP had been confirmed by surface biotinylation and immunoprecipitation with anti-GFP (data not shown). One clone (ACT5, mouse IgG1/κ) showed specific binding to TLR5-GFP expressing Ba/F3 cells and was studied further. ACT5 bound only to mouse TLR5-expressing BaκB cells, but not to human TLR5 expressing or plain BaκB cells (Fig. 1B) .
Furthermore, ACT5 was able to precipitate mouse TLR5 (Fig. 1C) . Meanwhile, ACT5 could not detect TLR5 protein in western blotting. These results demonstrated that ACT5 was anti-mouse TLR5 and that TLR5 was expressed on the cell surface of Ba/F3 transfectants.
PRAT4A is essential for cell surface expression of TLR5
We have previously reported that an ER-resident PRAT4A is required for cell surface expression of TLR4/MD-2, TLR1, TLR2 and RP105/MD-1 (18, 21) . We next tested the requirement for PRAT4A in cell surface expression of TLR5. We first studied physical association between TLR5 and PRAT4A. TLR5-GFP was expressed in Ba/F3 cells (Ba/F3_TLR5-GFP) and immunoprecipitated with anti-GFP. Coprecipitated, endogenous PRAT4A was detected by immunoprobing with anti-PRAT4A (Fig. 2A, lane 2) . On the other hand, when endogenous PRAT4A was immunoprecipitated, coprecipitated TLR5-GFP was successfully detected by anti-GFP. The low-molecular immature form of TLR5 was predominantly coprecipitated with PRAT4A rather than the mature form of TLR5 (Fig. 2A, lane 4) . In this regard, TLR5 is similar to TLR4 (19) . Given the physical association between TLR5 and PRAT4A, a role for PRAT4A in cell surface expression of TLR5 was next addressed. In TLR5-GFP expressing Ba/ F3, endogenous PRAT4A was silenced by shRNA up to 20% of PRAT4A in control Ba/F3 cells (Fig. 2B) . Despite the unaltered amount of TLR5-GFP as judged by GFP-fluorescence, cell surface TLR5 was almost all abolished by PRAT4A silencing (Fig. 2C) . Similar to the previous report for TLR4/MD-2 (19), the high-molecular mature form of TLR5 selectively disappeared by PRAT4A silencing (Fig. 2D) , demonstrating that post-translational maturation of TLR5 was severely impaired by PRAT4A silencing. To check the requirement for PRAT4A in TLR5 responses, PRAT4A mRNA was silenced in another Ba/F3 cell line expressing both untagged mouse TLR5 and an NF-κB-GFP reporter gene. Flagellin-dependent GFP induction was almost completely abrogated by PRAT4A silencing (Fig. 2E ). In consistent with our previous report (19) , TLR2-dependent GFP induction was much more resistant to PRAT4A silencing in this particular cell line.
PRAT4A requirement for endogenous TLR5 in a macrophage cell line J774
To study cell surface expression of endogenous TLR5 in immune cell lines, we stained various types of myeloid lineage cell lines including RAW264.7, J774, P388D1, M1 and 32D cells, and found that only J774 expressed TLR5 on the cell surface. This result was consistent with a previous report that TLR5 mRNA was detected in J774, but not in RAW264.7 and 32D (27) . Using J774 cells, we also examined PRAT4A requirement for cell surface expression of endogenous TLR5. When PRAT4A mRNA was silenced up to 10% (Fig. 3A) , cell surface expression of TLR4/MD-2, but not CD14, decreased, validating the effect of PRAT4A silencing (19, 21) . PRAT4A silencing apparently downregulated cell surface expression of TLR5 in J774 (Fig. 3B) . Flagellin stimulation of J774-induced IL-6 and G-CSF production (Fig. 3C ), which were completely abolished by PRAT4A silencing (Fig. 3C) . Taken together, PRAT4A was required for cell surface expression of and anti-flagellin responses via TLR5.
Cell surface TLR5 is expressed on neutrophils and Ly6C hi classical monocytes
As myeloid cell line J774 expressed cell surface TLR5 and previous reports suggested the reactivity of BM-DCs to flagellin (28, 29) , we first studied cell surface expression of TLR5 on M-CSF-induced CD11b + macrophages (BM-Macs), GM-CSF-induced CD11b + CD11c
+ BM-DCs. Neither BM-Macs nor BM-DCs showed cell surface expression of TLR5 at all (Fig. 4 ). In consistent with undetectable level of cell surface TLR5, BM-Macs and BM-DCs secreted none of cytokines such as TNF-α, IL-6, IL-10, IL-12p40, G-CSF, GM-CSF, MCP-1 and RANTES (regulated upon activation, normal T-cell expressed and secreted), in response to flagellin (data not shown).
To identify primary immune cell populations endogenously expressing cell surface TLR5, we next examined cells from thymus, spleen and BM. TLR5 + cells were barely detected by single color staining of thymuses or spleens (data not shown). Meanwhile, cell population with high side scatter in the BM was TLR5-positive (Fig. 5A) . This positive staining with ACT5 was not seen in the BM from TLR5 −/− or PRAT4A −/− mice, excluding nonspecific ACT5 binding to BM cells. TLR5 + BM cells Cell surface TLR5 617 expressed myeloid lineage markers including CD11b and Gr-1, but not other lineage markers such as B-cell lymphoid marker B220 or erythroid cell marker Ter119 (Fig. 5B) . Since Gr-1 detected both Ly6C and Ly6G (30), TLR5 + myeloid cells were further characterized by using anti-Ly6G and anti-Ly6C. Whole BM cells showed various staining patterns of Ly6C and Ly6G (Fig. 5C, left hi Ly6G − cells were monocytes marked by horseshoe-shaped nuclei with blue cytoplasm (Fig. 5D ). Both cell types sometimes showed mitoses. These cell surface maker and morphological profiles revealed that TLR5 + Ly6C int Ly6G + and TLR5 + Ly6C hi Ly6G − cells corresponded to neutrophils and classical monocytes, respectively.
Since BM cells are a source of peripheral neutrophils and monocytes, cell surface expression of TLR5 on CD11b + cells from blood and spleen were also studied. As in the BM, Ly6C int Ly6G + neutrophils from blood and spleen showed cell surface expression of TLR5 (Fig. 6A and 6B, region R1 ). According to previous reports (31), CD11b + Ly6G − monocytes can be subdivided by Ly6C staining into three subsets: Ly6C low (Fig. 6, region R2 (Fig. 6C) . At 72 h, only Ly6C low Ly6G − population was seen in the peritoneal cavity and did not express TLR5 on the cell surface (data not shown). All the ACT5 staining was completely lost on TLR5 −/− -derived cells (Fig. 6A-C and data not shown) , excluding nonspecific ACT5 binding to neutrophils and classical monocytes. These results suggested that the main immune cell populations expressing cell surface TLR5 were neutrophils and classical monocytes, which infiltrated into inflammatory sites during the acute phase, but not the late phase.
Classical monocytes, but not neutrophils, respond to flagellin and produce cytokines in acute inflammation
Flagellin administration in mice induces systemic cytokine release in a TLR5-dependent manner, and BM transfer revealed that immune cells are predominant cytokine producers for TNF-α, IL-6, IL-12p40 and MCP-1 in response to flagellin (32, 33) . However, immune cells responsible for cytokine production in acute inflammation have not yet been identified. As neutrophils and classical monocytes expressing cell surface TLR5 infiltrated into acute inflammatory lesion, TLR5-dependent cytokine production by these cells were studied. Neutrophils and classical monocytes were sorted from BM and stimulated by flagellin. Since anti-Ly6C (clone HK1.4) was reported to be an agonistic mAb (34), we alternatively used anti-Gr-1, which recognized both Ly6C and Ly6G, for sorting neutrophils and classical monocytes. In this staining, sorted neutrophils and classical monocytes were characterized by CD11b + Gr-1 hi Ly6G + and CD11b + Gr-1 hi Ly6G − , respectively (blue dots for neutrophils and black dots for classical monocytes in Fig. 7A ). Although constitutive production of IL-6 and MCP-1 was still observed after sorting, classical monocytes produced significant amount of IL-6 and MCP-1 in response to flagellin (Fig. 7B) , while neutrophils did not secrete those cytokines at all (Fig. 7C) . We also examined neutrophils and classical monocyes infiltrated into the peritoneal cavity by thioglycollate, and the production of IL-6 and MCP-1 by classical monocytes was augmented by flagellin again (data not shown). In contrast, no cytokine production was detected in flagellin-stimulated neutrophils. Thus, classical monocytes, but not neutrophils, were responsible for flagellin induced some types of cytokine production in acute inflammation.
Particular dendritic cell populations express cell surface TLR5
Previous studies have reported that flagellin stimulation induce maturation and cytokine production in DCs, with dominant antigen-presenting cells playing a key role in initiating adaptive immune responses (7, 12, 35, 36) . We examined cell surface expression of TLR5 in DCs. In intestinal lamina propria cells, CD11b hi CD11c hi DCs are reported to specifically express TLR5 mRNA and produce IL-6 and IL-12p40 in response against flagellin (36) (Fig. 8A) . Splenic DCs were also reported to highly express TLR5 and matured upon flagellin stimulation (12, 35) . Splenic DCs were subdivided into four populations based on cell surface markers: CD11c, PDCA-1, CD4 and CD8 (Fig. 8B) . CD11c int PDCA-1 + plasmacytoid DCs, but not CD11c hi PDCA-1 − conventional DCs, showed B220 expression (Fig.8C) , validating differential staining of pDCs and cDCs. CD8 − CD4
+ cDC showed higher expression of cell surface TLR5. Additionally, cell surface expression of TLR5 was also detected on pDCs and CD8 − CD4 − (double negative, DN) cDC (Fig. 8D) .
Discussion
A novel anti-TLR5 monoclonal antibody, ACT5, revealed the cell surface expression of TLR5 on immune cells. The recruitment of TLR5 to the cell surface was completely dependent on TLR-specific chaperone PRAT4A. In Ba/F3 cells, PRAT4A physically associated with TLR5. PRAT4A knock-down resulted in marked suppression of NF-κB activation in response to flagellin. In addition, in a macrophage cell line J774, PRAT4A silencing abolished cell surface expression of endogenous TLR5 and flagellin-dependent cytokine production. These results suggest that PRAT4A-dependent cell surface expression of TLR5 is required for flagellin-induced cytokine production. Previous studies report that PRAT4A associates with a general chaperone gp96 and restricts gp96 client to TLRs (21) . Taken together with the requirement of gp96 for flagellin response (20) , the present results demonstrate that TLR5 is another client of the chaperone complex PRAT4A-gp96.
It is well established that TLR5 activates MyD88-dependent signaling pathways to induce cytokine production and DC maturation (4, 12) . While cell surface TLR2/4-signaling 
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+ and Gr-1 hi Ly6G -population (right dot plots), respectively, these populations were sorted and used for cytokine assay. (B and C) Sorted classical monocytes (B) and neutrophils (C) from BM cells were stimulated by 100 ng ml -1 flagellin and cytokine production was analyzed by ELISA. Asterisks mean no signals were detected. requires a 'sorting adaptor', TIRAP, to recruit MyD88 to the cell surface TLR (17) , a previous report demonstrated that TLR5 does not need TIRAP for cytokine production (16) . Here, we confirm that TLR5 is another cell surface TLR, suggesting that MyD88 pathway from cell surface does not necessarily require TIRAP. TIRAP-independent MyD88 signaling from cell surface TLR5 may be a reason why flagellin, in contrast to LPS, is poor inflammatory and less relation to severe organ failure (37 All TLRs except TLR3 are expressed in human neutrophils and induce cytokine release, superoxide generation and CD62L shedding (38) . However, neutrophils from mouse BM or an inflammatory lesion did not produce cytokines in response to flagellin despite the expression of TLR5 on the cell surface. Given a role for TLR5 in phagocytosis and ROS production (39), cell surface TLR5 in neutrophils may principally contribute to direct pathogen clearance rather than to cytokine production.
Based on cell surface markers, mice monocytes are subcategorized into two major subsets (40 low CX 3 CR1 hi subset, nonclassical monocytes, has a remarkable patrolling activity and gives rise to resident macrophages after entering tissues. This study showed that TLR5 is expressed on Ly6C hi , but not on Ly6C low monocytes in the BM, circulation and inflammatory lesions. Flagellin is able to induce IL-6 and MCP-1 production via cell surface TLR5 from Ly6C hi monocytes, suggesting that classical monocytes are one of the main sources of flagellin-induced cytokines in acute inflammation. Considering that Ly6C hi classical monocytes contributes to the gut immune system and have a role in protection against an enteric bacterium (41), flagellin-induced cytokines from classical monocytes have an important role in augmenting acute inflammation at mucosa.
In addition to neutrophils and classical monocytes, very restricted expression of cell surface TLR5 was also found in DCs. First, cell surface TLR5 was detected on CD8α − cDCs, but not on CD8α + cDCs, in the spleen. CD8α − cDCs are more potent in activating CD4 + helper T cells than CD8α + cDCs, and associate with induction of T h 2-type response (42) . Considering that flagellin has been shown to have the potent adjuvant activity with a tendency to induce T h 2 response (12, 28), CD8α -cDCs, but not CD8α + cDCs, are likely to be required for the adjuvant activity of flagellin. Unexpectedly, splenic plasmacytoid DCs (pDCs), which is specialized to secrete large amounts of type I interferon, also express cell surface TLR5. As one report suggests that flagellin can induce IFN-β from BM-macrophages (43), flagellin may induce or augment the production of type I interferon in pDCs.
Against oral infection with a flagellated pathogen, TLR5 has a role in mounting adaptive immune responses (10, 36) . CD11b hi CD11c hi DCs in the lamina propria express TLR5 mRNA and have a key role in activating flagellin-dependent adaptive immune responses. Consistent with these previous reports, our results showed that only CD11b hi CD11c hi DCs expressed TLR5 on the cell surface. In contrast to these in vivo DCs, TLR5 is barely detectable on BM-DCs. Similarly, TLR5 is detectable on Ly6C hi monocytes in vivo but not on BM-macrophages. These results reveal that BM-derived DCs/ macrophages are distinct from in vivo DCs/macrophages. Unlike TLR2 and TLR4/MD-2, in vitro maturation induced by GM-CSF or M-CSF does not accompany cell surface expression of TLR5, implying that a signal is missing in in vitro maturation that induces cell surface TLR5.
In summary, our results show that TLR5 is expressed on the cell surface of neutrophils, classical monocytes and specific subpopulations of DCs, in a PRAT4A-dependent manner. The present result, however, does not necessarily exclude the possibility that intracellular TLR5 is functional. Although BM-DCs did not express cell surface TLR5, BM-DCs could respond to flagellin and induce DC maturation (12, 35) . In the case of TLR4/MD-2, intracellular TLR4/MD-2 in BM-macrophages is responsible for upregulation of costimulatory molecules and certain chemokine production (22) . Future studies need to focus on TLR5 inside the cells.
